Table 3 Patients (%) with global perceived effect on pain in the four arms of treatment and totals for the two treatments.
From: Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]
Treatment period | GBP-1= | Placebo-1= | Wash-out= | GBP-2= | Placebo-2= |
|---|---|---|---|---|---|
% some improvement (n) | 45% (10) | 13% (3) | 1 | 8% (2) | 13% (3) |
% much improvement (n) | 14% (3) | 5% (1) | 0 | 21% (5) | 4% (1) |
% total (n/N) | 59% (13/22) | a 17% (4/24) | 1 | 29% (7/24) | 18% (4/22) |
= | Total = GBP = | = | Total = placebo = | = | = |
% some improvement | 26% (12/46) | Â | 13% (6/46) | Â | Â |
% much improvement | 17% (8/46)β |  | 4% (2/46) |  |  |
% total (n/N) | 43% (20/46)a | Â | 17% (8/46) | Â | Â |
worsened | 13% (6/46) | Â | 9% (4/46) | Â | Â |